Meda Pharmaceuticals


Perrigo Files For Generic Astepro Nasal Spray, Patent Lawsuit

Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the United States Food and Drug Administration an Abbreviated New Drug Application for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals Inc., the owner of the New Drug Application of its filing.

WWJ Newsradio 950–01/23/2012